181 related articles for article (PubMed ID: 16682188)
1. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
2. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
4. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
5. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
[TBL] [Abstract][Full Text] [Related]
6. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
8. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
Al-Abed Y; Dabideen D; Aljabari B; Valster A; Messmer D; Ochani M; Tanovic M; Ochani K; Bacher M; Nicoletti F; Metz C; Pavlov VA; Miller EJ; Tracey KJ
J Biol Chem; 2005 Nov; 280(44):36541-4. PubMed ID: 16115897
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness.
Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Al-Abed Y; Stošić-Grujičić S; Vićovac Lj
Placenta; 2015 Feb; 36(2):150-9. PubMed ID: 25530499
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
12. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
13. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
Stojanovic I; Mirkov I; Kataranovski M; Glamoclija J; Stosic-Grujicic S
Immunobiology; 2011 Sep; 216(9):1018-27. PubMed ID: 21489649
[TBL] [Abstract][Full Text] [Related]
14. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
15. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Al-Abed Y; VanPatten S
Future Med Chem; 2011 Jan; 3(1):45-63. PubMed ID: 21428825
[TBL] [Abstract][Full Text] [Related]
16. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency.
Fischer-Valuck BW; Barrilleaux BL; Phinney DG; Russell KC; Prockop DJ; O'Connor KC
Biotechnol Lett; 2010 Jan; 32(1):19-27. PubMed ID: 19705068
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of macrophage migration inhibitory factor prevents thyroid dysfunction in pregnant rats with acute pancreatitis.
Chen Y; Wang CY; Zhao L; Hong YP; Zhang XY; Mei FC; Zhou Y; Guo WY; Shi Q; Zhao KL; Chen C; Yu J; Wang WX
Int Immunopharmacol; 2020 Oct; 87():106771. PubMed ID: 32683302
[TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Relationships and Anti-inflammatory Activities of N-Carbamothioylformamide Analogues as MIF Tautomerase Inhibitors.
Zhang Y; Xu L; Zhang Z; Zhang Z; Zheng L; Li D; Li Y; Liu F; Yu K; Hou T; Zhen X
J Chem Inf Model; 2015 Sep; 55(9):1994-2004. PubMed ID: 26288111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
